This compound is a deuterium-labeled derivative of nevirapine, an active pharmaceutical ingredient. It is primarily used as a reference standard in pharmaceutical research and quality control applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1051418-95-1
Tetrabutylammonium acetate
pharmaceutical raw material
Ne-58018
pharmaceutical raw material
Risedronic acid
pharmaceutical raw material
N-Acetyloxytocin
pharmaceutical raw material
11-Cyclopropyl-4-(²H₃)methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
pharmaceutical intermediate
DISCONTINUED See N391278
pharmaceutical raw material
Nevirapine
pharmaceutical raw material
2-Amino Nevirapine
pharmaceutical raw material
7-methyl-2-(2,2,3,3-tetradeuteriocyclopropyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
NQDJXKOVJZTUJA-CQOLUAMGSA-N
[2H]C1(C(C1([2H])[2H])N2C3=C(C=CC=N3)C(=O)NC4=C(C=CN=C42)C)[2H]
—